For decades, a patient with a worn-out, painful joint faced a fairly short menu: over-the-counter pain relievers, physical therapy, cortisone shots, and, when those stopped working, surgery. Today, there's a growing middle ground between "take ibuprofen" and "schedule a joint replacement," and much of it falls under one umbrella term: biologics.
The Problem Biologics Are Trying to Solve
Consider knee osteoarthritis (OA), the single most common reason patients pursue these treatments. OA involves the gradual wearing down of cartilage (the smooth, protective covering on the ends of your bones) along with degradation of the cushioning fluid inside the joint itself.
That fluid, called synovial fluid, is the joint’s built-in lubricant and shock absorber. Its major functional component is hyaluronic acid (HA), a naturally occurring molecule that gives the fluid its thick, viscous, protective quality. One of the early effects of osteoarthritis is the breakdown of this fluid; as it becomes thinner and less effective, friction, inflammation, and pain all increase with every step. Biologic therapies target this cascade at different points.
Hyaluronic Acid Injections (Viscosupplementation)
What it is: Hyaluronic acid injections, also called viscosupplementation, deliver HA directly into the joint space via an intra-articular injection. The goal is to restore the synovial fluid to a healthier, more protective state, improving lubrication and cushioning and reducing OA-related pain.
Who it’s for: HA injections are generally indicated for patients with knee OA pain who haven’t gotten adequate relief from conservative first steps such as simple analgesics, exercise, and physical therapy. It’s not typically the first move; it’s the next move when the basics aren’t enough.
What treatment looks like: Regimens vary by product. Some HA products are given as a series of three weekly injections, while others use a five-injection weekly course. Clinical research behind five-injection regimens has suggested that some patients begin to feel benefit after the third injection, and completing the full course is recommended for maximum benefit. Response time varies with the severity of arthritis, but many patients in clinical trials experienced meaningful relief after the third weekly injection, with benefits that can last up to six months.
Evidence and track record: HA has the largest published evidence base of any injectable knee OA treatment. Established HA products have decades of clinical use behind them. One widely used formulation is approved in 69 countries with tens of millions of syringes distributed worldwide, supported by long-duration double-blind clinical study data.
Practical notes: Patients are typically advised to avoid strenuous activity (jogging, tennis, heavy lifting) for about 48 hours after each injection, though most people resume normal daily activities quickly. Side effects are usually mild and local: temporary pain, swelling, or redness at the injection site. HA injections should be avoided by patients with known HA allergies or active infections or skin disease near the injection site. Many insurance carriers and Medicare cover viscosupplementation therapy, though coverage details vary by plan, and some manufacturers now offer direct-purchase programs for patients whose plans don’t cover it.
Hyaluronic Acid Injections (Viscosupplementation)
What it is: PRP is made from the patient’s own blood. A sample is drawn, spun in a centrifuge to concentrate the platelets (the cells rich in growth factors that orchestrate healing), and the resulting concentrate is injected into the joint or injured tissue.
Key Findings
- PRP has become one of the most studied orthobiologics, recently surpassing corticosteroids in total published research volume for knee OA.
- A 2025 narrative review synthesizing 40 high-quality studies found that PRP injections (particularly leukocyte-poor formulations) demonstrated better pain relief and functional improvement than both hyaluronic acid and corticosteroids, especially in patients with mild to moderate knee OA.
- Recent meta-analyses have highlighted an important contrast with cortisone: steroid shots often deliver short-term relief that fades within months, while PRP has shown more durable improvements in several trials.
The honest caveats: PRP preparation isn’t standardized. Platelet concentration, leukocyte content, activation methods, and injection schedules vary widely between clinics and studies, which makes results hard to compare. No major guideline currently considers PRP disease-modifying; the demonstrated benefit is symptomatic improvement, not cartilage regrowth. It also tends to work best when there’s still healthy cartilage remaining, so patients with severe “bone-on-bone” arthritis typically see less benefit. And because PRP is often not covered by insurance, out-of-pocket cost is a real factor.
Cell-Based and Emerging Therapies
The newest frontier includes cell-based therapies such as bone marrow aspirate concentrate (BMAC) and microfragmented adipose (fat) tissue (MFAT), along with combination approaches such as pairing HA with PRP to get both lubrication and growth-factor signaling in one protocol. Early comparative trials are promising: one two-year randomized trial found that microfragmented adipose tissue produced clinical outcomes comparable to a series of PRP-plus-HA injections in early knee OA. But the total volume of research here is still much smaller than for HA or PRP, and these therapies should generally be viewed as emerging rather than established.
Where Biologics Fit in a Modern Recovery Plan
- Foundation first. Activity modification, weight management, physical therapy, and simple analgesics remain the starting point for degenerative joint conditions.
- Biologics as the bridge. When conservative care isn’t enough but surgery isn’t yet necessary (or desirable), HA injections and PRP can reduce pain, improve function, and potentially delay the need for joint replacement by years.
- Surgery when it’s time. For end-stage arthritis or structural injuries, surgery remains the definitive answer. Even then, recovery science (including modalities like cold compression therapy) plays a major role in outcomes.
Questions to Ask Your Doctor
If you’re considering a biologic treatment, a few questions will get you to a well-informed decision quickly:
- Which treatment is best matched to the severity of my arthritis or injury?
- How many injections will I need, and over what schedule?
- What results should I realistically expect, and how long should they last?
- Is this covered by my insurance, and if not, what are the direct-pay options?
- What are the side effects, and is there any reason (allergy, infection, skin condition) I shouldn't receive this?
Disclaimer: This article is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Treatment decisions should always be made in consultation with your physician. All medical devices and injectable therapies carry inherent risks; refer to product labeling for indications, warnings, and contraindications.
References & Further Reading
- GenVisc 850 & TriVisc. About Knee Osteoarthritis & HA Injections: Patient FAQ.
- Corticosteroids, hyaluronic acid, platelet-rich plasma, and cell-based therapies for knee osteoarthritis: literature trends are shifting in the injectable treatments’ evidence. A systematic review and expert opinion. Expert Opinion on Biological Therapy. 2025;25:309–318.
- Platelet-rich plasma for knee osteoarthritis: a comprehensive narrative review of the mechanisms, preparation protocols, and clinical evidence. Journal of Clinical Medicine. 2025;14(11):3983.
- Xu H, et al. Comparison of hyaluronic acid and platelet-rich plasma in knee osteoarthritis: a systematic review. BMC Musculoskeletal Disorders. 2025;26(1).
- Advances in hyaluronic acid therapy for knee osteoarthritis: monotherapy and combination strategies. An evidence-based review. Orthopedic Reviews. 2026.